SAGENT
FDA Approves Unknown Drug — SAGENT PHARMS INC
# FDA Approves Generic Drug Application for Sagent Pharmaceuticals Sagent Pharmaceuticals Inc. received FDA approval for ANDA 203608 on May 11, 2017,...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Novartis
FDA Approves KISQALI FEMARA CO-PACK — Novartis Pharmaceuticals Corporation
Novartis has secured FDA approval for the co-packaged fixed-dose combination of KISQALI and Femara (ribociclib and letrozole), a strategic move aimed ...
AstraZeneca
FDA Approves IMFINZI — AstraZeneca Pharmaceuticals LP
# FDA Approves AstraZeneca's IMFINZI (Durvalumab) for Cancer Treatment AstraZeneca Pharmaceuticals LP has received FDA approval for IMFINZI (durvalum...
RISING
FDA Approves Unknown Drug — RISING
# FDA Approves Rising's Generic Drug Application The FDA approved ANDA200542 for Rising Pharmaceuticals on April 28, 2017, expanding the company's ge...
Apotex
FDA Approves AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE — Apotex Corp.
On April 28, the FDA approved a generic version of the nasal spray AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE manufactured by Apotex Corp., r...
Azurity
FDA Approves XATMEP — Azurity Pharmaceuticals, Inc.
# FDA Approves Azurity Pharmaceuticals' XATMEP Oral Methotrexate Formulation Azurity Pharmaceuticals has received FDA approval for XATMEP (methotrexa...
Protega
FDA Approves ROXYBOND — Protega Pharmaceuticals Inc
Protega Pharmaceuticals Inc. has received FDA approval for Roxycbond (oxycodone hydrochloride), a crucial strategic addition for the company intended ...
Unichem
FDA Approves PIROXICAM — Unichem Pharmaceuticals (USA), Inc.
# FDA Approves Piroxicam Generic for Unichem Pharmaceuticals Unichem Pharmaceuticals (USA), Inc. received FDA approval for its generic piroxicam oral...
RISING
FDA Approves Unknown Drug — RISING
# FDA Approves Rising Pharmaceuticals' Generic Drug Application Rising Pharmaceuticals has received FDA approval for an abbreviated new drug applicat...
RISING
FDA Approves Unknown Drug — RISING
# FDA Approves Rising Pharmaceuticals' Generic Drug Application Rising Pharmaceuticals has received FDA approval for ANDA200217, expanding its generi...
Genentech,
FDA Approves OCREVUS — Genentech, Inc.
# FDA Approves Genentech's OCREVUS for Multiple Sclerosis Treatment Genentech announced FDA approval of OCREVUS (ocrelizumab), an intravenous monoclo...
Camber
FDA Approves OXYCODONE AND ACETAMINOPHEN — Camber Pharmaceuticals, Inc.
Camber Pharmaceuticals gained FDA approval for its ANDA207419 formulation of oxycodone and acetaminophen tablets, granting the company the rights to s...
Aurobindo
FDA Approves TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN — Aurobindo Pharma Limited
The FDA has granted approval to Aurobindo Pharma Limited for its generic Tramadol Hydrochloride oral product, marking a new competitive entry into the...
Accord
FDA Approves OXALIPLATIN — Accord Healthcare Inc.
# FDA Approves Generic Oxaliplatin from Accord Healthcare Inc. Accord Healthcare Inc. received FDA approval for a generic version of oxaliplatin, an ...
Ascend
FDA Approves ROSUVASTATIN CALCIUM — Ascend Laboratories, LLC
On March 21, 2017, Ascend Laboratories, LLC received FDA approval for the ANDA for rosuvastatin calcium, a generic version of the widely used choleste...
TEVA
FDA Approves Unknown Drug — TEVA PHARMS USA
TEVA PHARMS USA reported the approval of its Abbreviated New Drug Application (ANDA 205807) on March 10, 2017, a milestone that positions the company ...
AMNEAL
FDA Approves Unknown Drug — AMNEAL PHARMS
On February 28, 2017, Amneal Pharmaceuticals received approval for ANDA 204741, a development that positions the company in significant market trial r...
RISING
FDA Approves Unknown Drug — RISING
Rising has received final FDA approval for its Abbreviated New Drug Application (ANDA #204043), positioning itself for entry into the market once the ...
ASTRAZENECA
FDA Approves Unknown Drug — ASTRAZENECA AB
# FDA Approves AstraZeneca Drug, Expanding Treatment Options in Key Therapeutic Area The U.S. Food and Drug Administration has approved AstraZeneca A...
Lupin
FDA Approves OXYCODONE AND ACETAMINOPHEN — Lupin Pharmaceuticals,Inc.
**FDA Approves ANDA for Lupin’s Oxycodone and Acetaminophen Combination Product** On February 24, 2017, the FDA approved Lupin Pharmaceuticals' Abbre...